Safety Alert

#	Title	Type of news	Date
135	Safety Signal of Erenumab and the Risk of Raynaud’s Phenomenon	Signal	2022-10-23
134	Safety Signal of Isotretinoin and the Risk of Blood Growth Hormone Decrease (BGHD)	Signal	2022-10-23
133	Safety Signal of Mycophenolic Acid and the Risk of Posterior Reversible Encephalopathy Syndrome (PRES)	Signal	2022-10-23
132	Safety Signal of Zoster Vaccine and the Risk of Stevens-Johnson syndrome	Signal	2022-09-25
131	Safety Signal of Olanzapine and the Risk of Congestive Cardiomyopathy	Signal	2022-09-25
130	Safety Signal of Duloxetine and the Risk of Hepatic Necrosis	Signal	2022-09-25
129	Safety Signal of Tetanus Toxoid (TT) Vaccine and Risk of Cellulitis	Signal	2022-08-09
128	Safety Signal of Olmesartan and Risk of Drug Induced Liver Injury	Signal	2022-08-09
127	Safety Signal of Everolimus and Risk of Osteonecrosis of Jaw	Signal	2022-08-09
126	Safety Signal of Docetaxel and Risk of Rhabdomyolysis	Signal	2022-07-31